Prialt Injection, Solution
Product Images NDC 68118-720

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Prialt (NDC 68118-720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Esteve Pharmaceuticals, S.a., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Prialt (68118-720-10)

PRIALT 100 mcg/mL injection solution label in a carton format. The label displays the proprietary name PRIALT, generic name ziconotide acetate, intrathecal infusion route, and instructions indicating its use with a microinfusion pump. The label notes the product is a sterile, preservative-free solution and includes storage instructions, NDC 68118-720-10, and the Esteve Pharmaceuticals, S.A. labeler information.*

FDA Label Image

Prialt (68118-722-10)

The packaging label for PRIALT 500 mcg/5 mL (100 mcg/mL) intrathecal infusion injection solution by Esteve Pharmaceuticals, S.A. The label includes storage instructions to refrigerate between 2-8°C, protect from light, and not freeze. It states the product is a sterile, preservative-free solution for use only with a microinfusion pump, specifically the Medtronic SynchroMed II and III systems.*

FDA Label Image

Prialt (68118-723-10)

The packaging label for PRIALT 500 mcg / 20 mL injection displays the brand name and generic name ziconotide intrathecal infusion prominently. It is a sterile, preservative-free solution for intrathecal infusion only with a microinfusion pump. The label includes storage instructions, NDC 68118-723-10, barcode, and manufacturer ESTEVE Pharmaceuticals, S.A. in Barcelona, Spain. Directions specify use with the Medtronic SynchroMed II and III infusion systems.*

FDA Label Image

Figure (Pri02 0000 01)

Chemical structure diagram representing the peptide sequence of ziconotide acetate, the active ingredient in PRIALT injection, solution.*

FDA Label Image

Figure 1 (Pri02 0000 02)

A bar chart comparing the percent of patients achieving various levels of percent improvement in pain from baseline between Ziconotide and placebo groups. The horizontal axis shows percent improvement in pain, ranging from >0 to ≥100, while the vertical axis indicates the percent of patients, ranging from 0% to 100%. Bars for Ziconotide are consistently higher than placebo across most improvement thresholds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.